Wang Li used to work as a highway surveyor in Southwest China’s Sichuan province. But after being diagnosed with multidrug-resistant tuberculosis (MDR-TB) in May 2023, the 25-year-old had to quit his job and stay at home. Wang told Caixin that his treatment regimen involves taking as many as 47 pills a day for up to 20 months.
In Depth: Behind China’s Struggle to Bring Down Drug-Resistant TB
2024年03月14日 18:24
Lack of early detection, slow rollout of new drugs and high cost of treatments are among factors frustrating efforts to control the infectious disease
[财新双语通产品，是为有双语需求读者专门订制的优惠产品， 按此可享超值优惠订阅。]
版面编辑：肖子何
图片推荐
视听推荐
编辑推荐
- 封面报道 | 求解产能过剩
- 专题报道 | 2024中国养老产业论坛
- 金融 | 证监会离职人员入股禁令升级
- 消费 | “五一”酒店量增价降 部分民宿尚未满房
- 世界 | 布林肯谈二度访华成果
最新文章
- 08:35T早报｜特斯拉通过数据安全合规要求；问...
- 08:15特斯拉达到中国汽车数据安全要求 不再受...
- 07:22亿航计划研发快充电池 提高航空器运营效率
- 07:18中国独角兽总估值1.4万亿美元 人工智...
- 07:14反腐记｜两名正省级 再上“伏虎”榜
- 07:08财经早知道｜李强：大力发展智能网联新能...
- 23:00楼市“网红”城市也扛不住了 成都长沙全...
- 22:36车展观察｜“红情绿意”触动中国车企流量焦虑
- 21:48北京物流仓储租金多年来首次下降 不同区...
- 21:39李强会见马斯克：平等合作、互利共赢才最...
京公网安备 11010502034662号 